Biotech Values

[DewDiligence]

The TAF top-line data from the two treatment-naïve trials are likely to come in 4Q14 or very late in September, and John Martin may have misspoken when he said “the current quarter” on yesterday’s CC.

On GILD’s 1Q14 CC in April, the guidance was for TAF top-line data in 4Q14 (#msg-100988940), and the clinicaltrials.gov listings show primary-endpoint completion in September 2015 (http://www.clinicaltrials.gov/ct2/show/NCT01797445, http://www.clinicaltrials.gov/ct2/show/NCT01780506 ), which doesn’t leave much time during 3Q14 for analysis prior to releasing the data.